ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

SBTX Skinbiotherapeutics Plc

8.85
0.00 (0.00%)
09 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Skinbiotherapeutics Plc LSE:SBTX London Ordinary Share GB00BF33H870 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 8.85 8.70 9.00 8.85 8.85 8.85 1,881,932 08:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Biological Pds,ex Diagnstics 132k -2.84M -0.0163 -5.43 15.4M
Skinbiotherapeutics Plc is listed in the Biological Pds,ex Diagnstics sector of the London Stock Exchange with ticker SBTX. The last closing price for Skinbiotherapeutics was 8.85p. Over the last year, Skinbiotherapeutics shares have traded in a share price range of 7.25p to 29.50p.

Skinbiotherapeutics currently has 174,004,323 shares in issue. The market capitalisation of Skinbiotherapeutics is £15.40 million. Skinbiotherapeutics has a price to earnings ratio (PE ratio) of -5.43.

Skinbiotherapeutics Share Discussion Threads

Showing 2001 to 2025 of 23625 messages
Chat Pages: Latest  81  80  79  78  77  76  75  74  73  72  71  70  Older
DateSubjectAuthorDiscuss
23/7/2018
22:32
Raf

He sold and the price went up.

Does it matter why he sold he still holds a good chunk.

As Elric said in stronger hands now.

S

shrewdmole
23/7/2018
16:16
Kids uni fee's lol in the price now.
slartybartfaster
23/7/2018
15:58
It was a sell. Wonder why he sold now?
rafboy
23/7/2018
14:51
2p profit per share for me and 43p with Opti. I'll be buzzing during my nigh shift tonight. Happy days are here to stay.
slartybartfaster
23/7/2018
13:54
Was he buying SBTX as well as OPTI?
deeppockets
23/7/2018
13:36
Mr mcgeever?
shrewdmole
23/7/2018
13:34
Sold into safe hands.
elrico
23/7/2018
13:19
That's the seller then.
matt123d
23/7/2018
13:00
Eyes on 20p, next area areas 21.5/22 then 32/33p.
matt123d
23/7/2018
12:57
Probably some selling OPTI and buying SBTX. I am surprised we have risen so far today but it was always going to get to these levels. Has happened sooner than I thought it would.
rafboy
23/7/2018
12:55
Not seeing much resistance on the chart other than previous highs. Is it too soon for a break out?
rathean
23/7/2018
12:13
Yes he did say that so around 80p. That will be after successful human skin trials and a commercial tie up I would think.
rafboy
23/7/2018
12:03
I think i remember SOH saying SBTX to be worth 100 mil.
anderson3
23/7/2018
10:45
Existing creams are also steroids are not great for you longer term whereas SBTX is a natural remedy so much better for the body. Win/win!
deeppockets
23/7/2018
10:06
Yes Raf - sbtx products will hopefully be widely available OTC and at a reasonable price.
Some of the existing prescription eczema creams are hugely expensive - if this one with Novartis is better than existing stuff, they will want a premium.

semper vigilans
23/7/2018
09:43
Successful human trial data in October will significantly reduce the risk profile of SBTX. We will then see the share price start to behave as its parent. Not long to wait.
elrico
23/7/2018
09:37
SV, that’s interesting. Thanks. I think people underestimate how far SBTX could go at their peril.
rafboy
23/7/2018
09:23
I see Novartis have just paid up to $1bn for an eczema drug?
semper vigilans
19/7/2018
16:16
Nobby - see reply. Good to chat.
elrico
19/7/2018
15:58
>>elrico

I have sent you a PM....

nobbygnome
19/7/2018
15:36
Nobby - With due respect, you and I know there are many reasons for a funding. Larva is suggesting a bailout placing. If I'm misrepresenting larva's comment, then I have afforded the opportunity to correct, thus far, no correction. OPTI took the opportunity to which the company had already issued a caveat to, and one I also flagged as the only reasons for a placing. OPTI's funding was to expedite a commercial opportunity they ran the risk of losing, the placing wasn't to keep the lights on, as our friend Michellemouse implied. The end result, pharma LP-LDL will be c12-18 months away, not several years.
elrico
19/7/2018
14:06
>> elrico

With all due respect it is dangerous to ask questions about fund raisings. Before the latest OPTI raise, you would have said they didn't need any more cash. But raise money they did....

nobbygnome
19/7/2018
14:01
lol larva, you must related to michaelmouse
slartybartfaster
19/7/2018
13:24
larva - out of interest, how much cash is left and how long do you expect it to last?

I guess here endeth the debate, as I don't expect you to answer either of those BASIC questions.

elrico
19/7/2018
13:00
Not much cash left

Placing at 5p?

larva
Chat Pages: Latest  81  80  79  78  77  76  75  74  73  72  71  70  Older

Your Recent History

Delayed Upgrade Clock